SINGAPORE: Temasek Holdings on Tuesday (July 8)
reported a 3.7 per cent increase in the net value of its investment
portfolio - from S$215 billion in 2013 to S$223 billion in the last
fiscal year.
In its annual Temasek Review report released on Tuesday, the investment company said Group net profit for the year ended March 31, 2014, rose 2.8 per cent to S$10.9 billion, from S$10.6 billion in the same period last year.
Total shareholder return (TSR), which is Temasek's key measure of performance, was 1.5 per cent for the past year, down from 8.6 per cent in the previous 12 months. It attributed this mainly to weakness in key Asian markets.
Temasek's five-year TSR was 11 per cent and
its 10-year TSR was 9 per cent, which the firm said reflects the steady growth in its portfolio.
Longer term 20-year TSR was 6 per cent, and
14 per cent for 30 years, it added.
FINANCIAL SERVICES, LIFE SCIENCES TOP INVESTMENT SECTORS
In the last fiscal year, Temasek invested a total of S$24 billion and divested nearly S$10 billion, for a total net investment of $14 billion.
Temasek Chairman Lim Boon Heng said in the statement that "this year has been one of our most active years for new investments - the most active since the Global Financial Crisis". The new investments are driven by the continued recovery in the global economy as well as lower asset prices in Asia, which offered attractive investment opportunities.
Temasek said the top three sectors for investments during the year were in financial services, life sciences and energy. Among its investments in financial services was the acquisition of a 1.1 per cent stake in United Kingdom-based Lloyds Banking Group.
In life sciences, Temasek invested almost US$1 billion in Gilead Sciences - a firm that develops treatments for cancer, HIV and infectious diseases. It also invested about S$2 billion in Pavilion Energy, which focuses on Liquefied Natural Gas (LNG) in the energy space.
Temasek's key divestments over the year included Singapore's Tiger Airways and part of its stake in India's Bharti Telecom.
It ended the year with an underlying portfolio exposure of 31 per cent in Singapore, 25 per cent in China and 10 per cent in Australia. However, its exposure in North America and Europe grew to over 14 per cent from 12 per cent in the previous year.
Looking ahead, Mr Lim said that there will be both challenges and opportunities with the rapidly changing world.
"Even as we mark our 40th anniversary, we embrace the future with all that it brings. At 40, our journey has just begun," he added.
In its annual Temasek Review report released on Tuesday, the investment company said Group net profit for the year ended March 31, 2014, rose 2.8 per cent to S$10.9 billion, from S$10.6 billion in the same period last year.
Total shareholder return (TSR), which is Temasek's key measure of performance, was 1.5 per cent for the past year, down from 8.6 per cent in the previous 12 months. It attributed this mainly to weakness in key Asian markets.
Temasek's five-year TSR was 11 per cent and
its 10-year TSR was 9 per cent, which the firm said reflects the steady growth in its portfolio.
Longer term 20-year TSR was 6 per cent, and
14 per cent for 30 years, it added.
FINANCIAL SERVICES, LIFE SCIENCES TOP INVESTMENT SECTORS
In the last fiscal year, Temasek invested a total of S$24 billion and divested nearly S$10 billion, for a total net investment of $14 billion.
Temasek Chairman Lim Boon Heng said in the statement that "this year has been one of our most active years for new investments - the most active since the Global Financial Crisis". The new investments are driven by the continued recovery in the global economy as well as lower asset prices in Asia, which offered attractive investment opportunities.
Temasek said the top three sectors for investments during the year were in financial services, life sciences and energy. Among its investments in financial services was the acquisition of a 1.1 per cent stake in United Kingdom-based Lloyds Banking Group.
In life sciences, Temasek invested almost US$1 billion in Gilead Sciences - a firm that develops treatments for cancer, HIV and infectious diseases. It also invested about S$2 billion in Pavilion Energy, which focuses on Liquefied Natural Gas (LNG) in the energy space.
Temasek's key divestments over the year included Singapore's Tiger Airways and part of its stake in India's Bharti Telecom.
It ended the year with an underlying portfolio exposure of 31 per cent in Singapore, 25 per cent in China and 10 per cent in Australia. However, its exposure in North America and Europe grew to over 14 per cent from 12 per cent in the previous year.
Looking ahead, Mr Lim said that there will be both challenges and opportunities with the rapidly changing world.
"Even as we mark our 40th anniversary, we embrace the future with all that it brings. At 40, our journey has just begun," he added.
- CNA/kk
Posts
I am stock broker and I am really intrastate to get useful information about my business. This is nice and informative blog I got here. Thanks for posting Australian shareholder centre
ReplyDelete